Erythrodermic psoriasis secondary to systemic corticosteroids.
Erythroderma
erythrodermic psoriasis
psoriasis
systemic corticosteroids
topicals
Journal
Proceedings (Baylor University. Medical Center)
ISSN: 0899-8280
Titre abrégé: Proc (Bayl Univ Med Cent)
Pays: United States
ID NLM: 9302033
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
17
08
2019
revised:
15
10
2019
accepted:
28
10
2019
entrez:
18
2
2020
pubmed:
18
2
2020
medline:
18
2
2020
Statut:
epublish
Résumé
Erythroderma is an uncommon, potentially life-threatening condition, which has many causes, including uncontrolled psoriasis. We present a 58-year-old woman with psoriasis who, after an abrupt discontinuation of systemic corticosteroids, developed erythrodermic psoriasis with extensive body surface involvement requiring hospital admission. Erythrodermic psoriasis requires a high index of suspicion to diagnose it in a timely fashion and treat it to prevent complications.
Identifiants
pubmed: 32063793
doi: 10.1080/08998280.2019.1686911
pii: 1686911
pmc: PMC6988617
doi:
Types de publication
Case Reports
Langues
eng
Pagination
113-114Informations de copyright
Copyright © 2020 Baylor University Medical Center.
Références
Cureus. 2017 Dec 11;9(12):e1936
pubmed: 29464143
Adv Skin Wound Care. 2015 May;28(5):228-36; quiz 237-8
pubmed: 25882661
J Am Acad Dermatol. 1989 Nov;21(5 Pt 1):985-91
pubmed: 2530253
Br J Dermatol. 2016 Jun;174(6):1194-227
pubmed: 27317286
J Am Acad Dermatol. 2010 Apr;62(4):655-62
pubmed: 19665821
Am J Clin Dermatol. 2010;11(3):157-70
pubmed: 20184391
Psoriasis (Auckl). 2016;6:93-104
pubmed: 28856115
J Am Acad Dermatol. 2012 Mar;66(3):503-8
pubmed: 22005074
An Bras Dermatol. 2018 Jul-Aug;93(4):598-600
pubmed: 30066777